AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis
- PMID: 38489523
- DOI: 10.1097/HEP.0000000000000845
AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis
Comment in
-
Serologic noninvasive liver disease assessments: clinical utility and future potential.Hepatobiliary Surg Nutr. 2025 Feb 1;14(1):151-154. doi: 10.21037/hbsn-2024-661. Epub 2025 Jan 9. Hepatobiliary Surg Nutr. 2025. PMID: 39925898 Free PMC article. No abstract available.
-
Non-invasive liver disease assessments: can they replace liver biopsy?Hepatobiliary Surg Nutr. 2025 Feb 1;14(1):147-150. doi: 10.21037/hbsn-2024-658. Epub 2025 Jan 10. Hepatobiliary Surg Nutr. 2025. PMID: 39925913 Free PMC article. No abstract available.
References
-
- Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol. 2020;18:2650–2666.
-
- Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70:151–171.
-
- Sterling RK, Duarte-Rojo A, Patel K, Asrani SK, Alsawas M, Dranoff J, et al. AASLD Practice Guideline on imaging-based non-invasive liver disease assessments of hepatic fibrosis and steatosis. Hepatology. 2024. doi:10.1097/HEP.0000000000000843 - DOI
-
- Duarte-Rojo A, Taouli B, Leung DH, Levine D, Nayfeh T, Hasan B, et al. Imaging-based non-invasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline. Hepatology. 2024. doi:10.1097/HEP.0000000000000852 - DOI
-
- Sterling RK, Asrani SK, Levine D, Duarte-Rojo A, Patel K, Fiel MI, et al. AASLD Practice Guideline on non-invasive liver disease assessments of portal hypertension. Hepatology. 2024. doi:10.1097/HEP.0000000000000844 - DOI
LinkOut - more resources
Full Text Sources
